Mental and Behavioural Disorders

2

Review clinical trials related to Mental and Behavioural Disorders. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

INNOV5-MH-MAROC: Integrated Mental Health Care for Adolescents and Adults in Primary Care Centers and Schools in Morocco

Depression and anxiety are highly prevalent among adolescents and adults in Morocco, while access to evidence-based care in primary care centers and schools remains limited. This multicenter pragmatic randomized controlled trial evaluates an integrated mental health program inspired by WHO priorities. The INNOV5 intervention combines: (1) a collaborative care model in primary care; (2) mhGAP-based task-shifting and stepped care; (3) validated digital mental health interventions; (4) virtual reality exposure therapy for selected anxiety- or trauma-related cases; and (5) a school-based mental health promotion component in participating high schools. The primary objective is to compare the change in depressive symptoms (PHQ-9) at 6 months between INNOV5 and enhanced treatment as usual (TAU+). Secondary objectives include effects on anxiety (GAD-7), quality of life (WHOQOL-BREF), suicidal ideation and behavior (C-SSRS), functioning, school attendance, and feasibility and acceptability of the program.

Participants needed: 146
Trial details
Age: 12+Biological sex: AllType: InterventionalSponsor: Swiss Medical Academy MarocUpdated: Dec 2, 2025Locations: 1
Eligibility criteria

Adolescents (12-17 years) and adults (≥18 years) attending participating primary... [+3]

Acute psychiatric emergency requiring immediate specialised care (e.g. psychosis... [+3]

Status: Recruiting

AnovaOS Network Powered Patient Registry

The objective of this study is the development, implementation and management of a registry of patient data that captures clinically meaningful, real-world, data on the diagnosis, nature, course of infection, treatment(s) and outcomes in patients with complex disease globally.

Participants needed: 100,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Anova Enterprises, IncUpdated: Jan 30, 2024Locations: 1Duration: 5 Years
Eligibility criteria

18 years old or older; [+5]

Subjects who do not meet the inclusion criteria for the study; [+1]